Is polypharmacy associated with duplicated therapy and contraindicated drug combinations in the elderly?
Polypharmacy in the elderly is associated with duplicated therapy and contraindicated drug combinations, highlighting the need for improved communication among healthcare providers and patients.
As shown by this study, polypharmacy was associated with duplicated therapy and contraindicated drug combinations. Improved communications among seniors, physicians, and pharmacists is necessary to minimize adverse consequences of polypharmacy.
Golchin et al. (2015) studied this question.